nodes	percent_of_prediction	percent_of_DWPC	metapath
Abiraterone—ABCC1—Dactinomycin—peripheral nervous system neoplasm	0.155	0.213	CbGbCtD
Abiraterone—ABCC1—Epirubicin—peripheral nervous system neoplasm	0.112	0.155	CbGbCtD
Abiraterone—ABCC1—Vincristine—peripheral nervous system neoplasm	0.0955	0.131	CbGbCtD
Abiraterone—ABCC1—Etoposide—peripheral nervous system neoplasm	0.0875	0.12	CbGbCtD
Abiraterone—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0741	0.102	CbGbCtD
Abiraterone—ABCC1—Doxorubicin—peripheral nervous system neoplasm	0.0597	0.0822	CbGbCtD
Abiraterone—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0323	0.0445	CbGbCtD
Abiraterone—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0312	0.0429	CbGbCtD
Abiraterone—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0301	0.0414	CbGbCtD
Abiraterone—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0138	0.019	CbGbCtD
Abiraterone—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0136	0.0187	CbGbCtD
Abiraterone—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0126	0.0174	CbGbCtD
Abiraterone—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00863	0.0119	CbGbCtD
Abiraterone—CYP17A1—Androgen biosynthesis—HSD17B12—peripheral nervous system neoplasm	0.00455	0.238	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of steroid hormones and vitamin D—HSD17B12—peripheral nervous system neoplasm	0.00189	0.0987	CbGpPWpGaD
Abiraterone—SULT2A1—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.00169	0.0881	CbGpPWpGaD
Abiraterone—SULT2A1—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.00102	0.0531	CbGpPWpGaD
Abiraterone—SULT2A1—Fatty acid, triacylglycerol, and ketone body metabolism—HSD17B12—peripheral nervous system neoplasm	0.000916	0.0479	CbGpPWpGaD
Abiraterone—ABCC1—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000837	0.0437	CbGpPWpGaD
Abiraterone—Angiopathy—Vincristine—peripheral nervous system neoplasm	0.00053	0.00208	CcSEcCtD
Abiraterone—Phosphatase alkaline increased—Epirubicin—peripheral nervous system neoplasm	0.000529	0.00208	CcSEcCtD
Abiraterone—Infestation NOS—Etoposide—peripheral nervous system neoplasm	0.000527	0.00207	CcSEcCtD
Abiraterone—Infestation—Etoposide—peripheral nervous system neoplasm	0.000527	0.00207	CcSEcCtD
Abiraterone—Nocturia—Doxorubicin—peripheral nervous system neoplasm	0.000527	0.00207	CcSEcCtD
Abiraterone—Mediastinal disorder—Vincristine—peripheral nervous system neoplasm	0.000527	0.00207	CcSEcCtD
Abiraterone—Anaemia—Dactinomycin—peripheral nervous system neoplasm	0.000526	0.00207	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.000522	0.00205	CcSEcCtD
Abiraterone—Acute coronary syndrome—Etoposide—peripheral nervous system neoplasm	0.00052	0.00204	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.000518	0.00204	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.000518	0.00204	CcSEcCtD
Abiraterone—Myocardial infarction—Etoposide—peripheral nervous system neoplasm	0.000517	0.00203	CcSEcCtD
Abiraterone—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.000514	0.00202	CcSEcCtD
Abiraterone—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.000514	0.00202	CcSEcCtD
Abiraterone—Mental disorder—Vincristine—peripheral nervous system neoplasm	0.000512	0.00201	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.000511	0.00201	CcSEcCtD
Abiraterone—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.000511	0.00201	CcSEcCtD
Abiraterone—Urinary tract disorder—Cisplatin—peripheral nervous system neoplasm	0.00051	0.00201	CcSEcCtD
Abiraterone—Connective tissue disorder—Cisplatin—peripheral nervous system neoplasm	0.000508	0.002	CcSEcCtD
Abiraterone—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.000507	0.00199	CcSEcCtD
Abiraterone—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.000507	0.00199	CcSEcCtD
Abiraterone—Urethral disorder—Cisplatin—peripheral nervous system neoplasm	0.000507	0.00199	CcSEcCtD
Abiraterone—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.000505	0.00198	CcSEcCtD
Abiraterone—Fluid retention—Epirubicin—peripheral nervous system neoplasm	0.000502	0.00197	CcSEcCtD
Abiraterone—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.000501	0.00197	CcSEcCtD
Abiraterone—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.000501	0.00197	CcSEcCtD
Abiraterone—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.0005	0.00197	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000495	0.00194	CcSEcCtD
Abiraterone—Fatigue—Topotecan—peripheral nervous system neoplasm	0.000494	0.00194	CcSEcCtD
Abiraterone—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.000494	0.00194	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000491	0.00193	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000491	0.00193	CcSEcCtD
Abiraterone—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.00049	0.00193	CcSEcCtD
Abiraterone—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.00049	0.00193	CcSEcCtD
Abiraterone—Constipation—Topotecan—peripheral nervous system neoplasm	0.00049	0.00193	CcSEcCtD
Abiraterone—Phosphatase alkaline increased—Doxorubicin—peripheral nervous system neoplasm	0.000489	0.00192	CcSEcCtD
Abiraterone—Anaemia—Alitretinoin—peripheral nervous system neoplasm	0.000488	0.00192	CcSEcCtD
Abiraterone—Constipation—Tretinoin—peripheral nervous system neoplasm	0.000486	0.00191	CcSEcCtD
Abiraterone—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.000486	0.00191	CcSEcCtD
Abiraterone—Myalgia—Dactinomycin—peripheral nervous system neoplasm	0.000485	0.00191	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000485	0.0019	CcSEcCtD
Abiraterone—Fatigue—Melphalan—peripheral nervous system neoplasm	0.000484	0.0019	CcSEcCtD
Abiraterone—Cardiac disorder—Cisplatin—peripheral nervous system neoplasm	0.00048	0.00188	CcSEcCtD
Abiraterone—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000479	0.00188	CcSEcCtD
Abiraterone—Anaemia—Vincristine—peripheral nervous system neoplasm	0.00047	0.00185	CcSEcCtD
Abiraterone—Urinary tract disorder—Etoposide—peripheral nervous system neoplasm	0.000468	0.00184	CcSEcCtD
Abiraterone—Mediastinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000466	0.00183	CcSEcCtD
Abiraterone—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.000465	0.00183	CcSEcCtD
Abiraterone—Fluid retention—Doxorubicin—peripheral nervous system neoplasm	0.000464	0.00182	CcSEcCtD
Abiraterone—Urethral disorder—Etoposide—peripheral nervous system neoplasm	0.000464	0.00182	CcSEcCtD
Abiraterone—Infection—Dactinomycin—peripheral nervous system neoplasm	0.000462	0.00181	CcSEcCtD
Abiraterone—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.000462	0.00181	CcSEcCtD
Abiraterone—Cough—Alitretinoin—peripheral nervous system neoplasm	0.000461	0.00181	CcSEcCtD
Abiraterone—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.000456	0.00179	CcSEcCtD
Abiraterone—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000453	0.00178	CcSEcCtD
Abiraterone—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.00045	0.00177	CcSEcCtD
Abiraterone—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.00045	0.00177	CcSEcCtD
Abiraterone—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00045	0.00177	CcSEcCtD
Abiraterone—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00045	0.00177	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000446	0.00175	CcSEcCtD
Abiraterone—SULT2A1—Corticotropin-releasing hormone—GNAS—peripheral nervous system neoplasm	0.000445	0.0233	CbGpPWpGaD
Abiraterone—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000444	0.00175	CcSEcCtD
Abiraterone—CYP2D6—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000442	0.0231	CbGpPWpGaD
Abiraterone—Blood alkaline phosphatase increased—Epirubicin—peripheral nervous system neoplasm	0.000441	0.00173	CcSEcCtD
Abiraterone—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.000439	0.00173	CcSEcCtD
Abiraterone—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000439	0.00173	CcSEcCtD
Abiraterone—Myalgia—Vincristine—peripheral nervous system neoplasm	0.000433	0.0017	CcSEcCtD
Abiraterone—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000431	0.00169	CcSEcCtD
Abiraterone—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.00043	0.00169	CcSEcCtD
Abiraterone—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000428	0.00168	CcSEcCtD
Abiraterone—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.000427	0.00168	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000423	0.00166	CcSEcCtD
Abiraterone—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000419	0.00164	CcSEcCtD
Abiraterone—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000416	0.00163	CcSEcCtD
Abiraterone—Oedema—Vincristine—peripheral nervous system neoplasm	0.000415	0.00163	CcSEcCtD
Abiraterone—Infection—Vincristine—peripheral nervous system neoplasm	0.000413	0.00162	CcSEcCtD
Abiraterone—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000411	0.00162	CcSEcCtD
Abiraterone—Hot flush—Epirubicin—peripheral nervous system neoplasm	0.00041	0.00161	CcSEcCtD
Abiraterone—Blood alkaline phosphatase increased—Doxorubicin—peripheral nervous system neoplasm	0.000408	0.0016	CcSEcCtD
Abiraterone—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000408	0.0016	CcSEcCtD
Abiraterone—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000408	0.0016	CcSEcCtD
Abiraterone—Menopausal symptoms—Epirubicin—peripheral nervous system neoplasm	0.000407	0.0016	CcSEcCtD
Abiraterone—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000403	0.00158	CcSEcCtD
Abiraterone—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000401	0.00157	CcSEcCtD
Abiraterone—Cardiac failure—Epirubicin—peripheral nervous system neoplasm	0.000393	0.00154	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000393	0.00154	CcSEcCtD
Abiraterone—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000392	0.00154	CcSEcCtD
Abiraterone—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.00039	0.00153	CcSEcCtD
Abiraterone—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000389	0.00153	CcSEcCtD
Abiraterone—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000389	0.00153	CcSEcCtD
Abiraterone—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000384	0.00151	CcSEcCtD
Abiraterone—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000384	0.00151	CcSEcCtD
Abiraterone—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000383	0.0015	CcSEcCtD
Abiraterone—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000381	0.0015	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00038	0.00149	CcSEcCtD
Abiraterone—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.00038	0.00149	CcSEcCtD
Abiraterone—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000379	0.00149	CcSEcCtD
Abiraterone—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000378	0.00149	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000378	0.00149	CcSEcCtD
Abiraterone—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.000376	0.00148	CcSEcCtD
Abiraterone—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000376	0.00148	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000372	0.00146	CcSEcCtD
Abiraterone—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000372	0.00146	CcSEcCtD
Abiraterone—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000369	0.00145	CcSEcCtD
Abiraterone—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000367	0.00144	CcSEcCtD
Abiraterone—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000367	0.00144	CcSEcCtD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000365	0.0191	CbGpPWpGaD
Abiraterone—Infection—Cisplatin—peripheral nervous system neoplasm	0.000365	0.00143	CcSEcCtD
Abiraterone—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000364	0.00143	CcSEcCtD
Abiraterone—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000364	0.00143	CcSEcCtD
Abiraterone—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000362	0.00142	CcSEcCtD
Abiraterone—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000362	0.00142	CcSEcCtD
Abiraterone—Rash—Topotecan—peripheral nervous system neoplasm	0.000361	0.00142	CcSEcCtD
Abiraterone—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000361	0.00142	CcSEcCtD
Abiraterone—Cough—Etoposide—peripheral nervous system neoplasm	0.00036	0.00141	CcSEcCtD
Abiraterone—Rash—Tretinoin—peripheral nervous system neoplasm	0.000359	0.00141	CcSEcCtD
Abiraterone—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000359	0.00141	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000359	0.00141	CcSEcCtD
Abiraterone—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000358	0.00141	CcSEcCtD
Abiraterone—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000358	0.00141	CcSEcCtD
Abiraterone—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000358	0.00141	CcSEcCtD
Abiraterone—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000357	0.0014	CcSEcCtD
Abiraterone—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000357	0.0014	CcSEcCtD
Abiraterone—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000356	0.0014	CcSEcCtD
Abiraterone—Constipation—Vincristine—peripheral nervous system neoplasm	0.000355	0.0014	CcSEcCtD
Abiraterone—Rash—Melphalan—peripheral nervous system neoplasm	0.000354	0.00139	CcSEcCtD
Abiraterone—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000354	0.00139	CcSEcCtD
Abiraterone—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000351	0.00138	CcSEcCtD
Abiraterone—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000349	0.00137	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000349	0.00137	CcSEcCtD
Abiraterone—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000347	0.00136	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000346	0.00136	CcSEcCtD
Abiraterone—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000343	0.00135	CcSEcCtD
Abiraterone—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000341	0.00134	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000338	0.00133	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000335	0.00131	CcSEcCtD
Abiraterone—Infection—Etoposide—peripheral nervous system neoplasm	0.000334	0.00131	CcSEcCtD
Abiraterone—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000334	0.00131	CcSEcCtD
Abiraterone—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000328	0.00129	CcSEcCtD
Abiraterone—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000327	0.00129	CcSEcCtD
Abiraterone—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000327	0.00128	CcSEcCtD
Abiraterone—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000323	0.00127	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.00126	CcSEcCtD
Abiraterone—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000318	0.00125	CcSEcCtD
Abiraterone—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000317	0.00125	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000317	0.00125	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000313	0.00123	CcSEcCtD
Abiraterone—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000309	0.00121	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000308	0.00121	CcSEcCtD
Abiraterone—SULT2A1—E2F transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000308	0.0161	CbGpPWpGaD
Abiraterone—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000306	0.0012	CcSEcCtD
Abiraterone—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.0003	0.00118	CcSEcCtD
Abiraterone—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000299	0.00118	CcSEcCtD
Abiraterone—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000298	0.00117	CcSEcCtD
Abiraterone—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000297	0.00117	CcSEcCtD
Abiraterone—ABCC1—ABC-family proteins mediated transport—ABCB1—peripheral nervous system neoplasm	0.000296	0.0155	CbGpPWpGaD
Abiraterone—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000296	0.00116	CcSEcCtD
Abiraterone—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000296	0.00116	CcSEcCtD
Abiraterone—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000296	0.00116	CcSEcCtD
Abiraterone—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000295	0.00116	CcSEcCtD
Abiraterone—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000293	0.00115	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00029	0.00114	CcSEcCtD
Abiraterone—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00029	0.00114	CcSEcCtD
Abiraterone—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00029	0.00114	CcSEcCtD
Abiraterone—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000289	0.0151	CbGpPWpGaD
Abiraterone—Constipation—Etoposide—peripheral nervous system neoplasm	0.000288	0.00113	CcSEcCtD
Abiraterone—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000287	0.00113	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.00112	CcSEcCtD
Abiraterone—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000284	0.00112	CcSEcCtD
Abiraterone—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.00111	CcSEcCtD
Abiraterone—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000282	0.00111	CcSEcCtD
Abiraterone—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000277	0.00109	CcSEcCtD
Abiraterone—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.00108	CcSEcCtD
Abiraterone—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000274	0.00108	CcSEcCtD
Abiraterone—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.00107	CcSEcCtD
Abiraterone—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.00107	CcSEcCtD
Abiraterone—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000272	0.00107	CcSEcCtD
Abiraterone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000271	0.00107	CcSEcCtD
Abiraterone—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000266	0.00104	CcSEcCtD
Abiraterone—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.00104	CcSEcCtD
Abiraterone—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000264	0.00104	CcSEcCtD
Abiraterone—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000263	0.00104	CcSEcCtD
Abiraterone—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000262	0.00103	CcSEcCtD
Abiraterone—Rash—Vincristine—peripheral nervous system neoplasm	0.000262	0.00103	CcSEcCtD
Abiraterone—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000262	0.00103	CcSEcCtD
Abiraterone—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.00102	CcSEcCtD
Abiraterone—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000261	0.00102	CcSEcCtD
Abiraterone—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.00026	0.00102	CcSEcCtD
Abiraterone—ALB—FOXA2 and FOXA3 transcription factor networks—NF1—peripheral nervous system neoplasm	0.000258	0.0135	CbGpPWpGaD
Abiraterone—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000251	0.000987	CcSEcCtD
Abiraterone—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000246	0.000968	CcSEcCtD
Abiraterone—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000245	0.0128	CbGpPWpGaD
Abiraterone—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000953	CcSEcCtD
Abiraterone—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000241	0.000948	CcSEcCtD
Abiraterone—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.000948	CcSEcCtD
Abiraterone—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000946	CcSEcCtD
Abiraterone—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.000946	CcSEcCtD
Abiraterone—SULT2A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000241	0.0126	CbGpPWpGaD
Abiraterone—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000239	0.00094	CcSEcCtD
Abiraterone—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000237	0.000932	CcSEcCtD
Abiraterone—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000233	0.000917	CcSEcCtD
Abiraterone—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000233	0.000914	CcSEcCtD
Abiraterone—Rash—Cisplatin—peripheral nervous system neoplasm	0.000232	0.00091	CcSEcCtD
Abiraterone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000231	0.000909	CcSEcCtD
Abiraterone—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00023	0.000904	CcSEcCtD
Abiraterone—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000896	CcSEcCtD
Abiraterone—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000875	CcSEcCtD
Abiraterone—SULT2A1—Corticotropin-releasing hormone—CASP3—peripheral nervous system neoplasm	0.000222	0.0116	CbGpPWpGaD
Abiraterone—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.00087	CcSEcCtD
Abiraterone—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000862	CcSEcCtD
Abiraterone—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000845	CcSEcCtD
Abiraterone—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000214	0.00084	CcSEcCtD
Abiraterone—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000839	CcSEcCtD
Abiraterone—Rash—Etoposide—peripheral nervous system neoplasm	0.000212	0.000833	CcSEcCtD
Abiraterone—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000212	0.000833	CcSEcCtD
Abiraterone—SULT2A1—E2F transcription factor network—MYC—peripheral nervous system neoplasm	0.000209	0.0109	CbGpPWpGaD
Abiraterone—Cough—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000792	CcSEcCtD
Abiraterone—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000199	0.000784	CcSEcCtD
Abiraterone—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000776	CcSEcCtD
Abiraterone—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000773	CcSEcCtD
Abiraterone—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000773	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000768	CcSEcCtD
Abiraterone—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000194	0.000764	CcSEcCtD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000194	0.0101	CbGpPWpGaD
Abiraterone—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000741	CcSEcCtD
Abiraterone—Infection—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000736	CcSEcCtD
Abiraterone—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000733	CcSEcCtD
Abiraterone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—peripheral nervous system neoplasm	0.000185	0.00968	CbGpPWpGaD
Abiraterone—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000725	CcSEcCtD
Abiraterone—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000183	0.00072	CcSEcCtD
Abiraterone—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000715	CcSEcCtD
Abiraterone—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000715	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.00071	CcSEcCtD
Abiraterone—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000707	CcSEcCtD
Abiraterone—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000686	CcSEcCtD
Abiraterone—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000681	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000675	CcSEcCtD
Abiraterone—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000171	0.00067	CcSEcCtD
Abiraterone—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000666	CcSEcCtD
Abiraterone—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000661	CcSEcCtD
Abiraterone—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000652	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000163	0.00064	CcSEcCtD
Abiraterone—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000639	CcSEcCtD
Abiraterone—SULT2A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000162	0.00849	CbGpPWpGaD
Abiraterone—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000634	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000625	CcSEcCtD
Abiraterone—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000158	0.00827	CbGpPWpGaD
Abiraterone—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.00062	CcSEcCtD
Abiraterone—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000611	CcSEcCtD
Abiraterone—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000603	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000592	CcSEcCtD
Abiraterone—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000591	CcSEcCtD
Abiraterone—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000586	CcSEcCtD
Abiraterone—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000586	CcSEcCtD
Abiraterone—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000542	CcSEcCtD
Abiraterone—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000532	CcSEcCtD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000135	0.00706	CbGpPWpGaD
Abiraterone—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000507	CcSEcCtD
Abiraterone—CYP17A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000128	0.00667	CbGpPWpGaD
Abiraterone—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000492	CcSEcCtD
Abiraterone—SULT2A1—Corticotropin-releasing hormone—AKT1—peripheral nervous system neoplasm	0.00012	0.00628	CbGpPWpGaD
Abiraterone—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000471	CcSEcCtD
Abiraterone—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000469	CcSEcCtD
Abiraterone—Rash—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000467	CcSEcCtD
Abiraterone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000467	CcSEcCtD
Abiraterone—SULT2A1—Metabolism—GNS—peripheral nervous system neoplasm	0.000117	0.00614	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000117	0.0061	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—NME1—peripheral nervous system neoplasm	0.000113	0.00588	CbGpPWpGaD
Abiraterone—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000436	CcSEcCtD
Abiraterone—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000432	CcSEcCtD
Abiraterone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000432	CcSEcCtD
Abiraterone—SULT2A1—Metabolism—COX2—peripheral nervous system neoplasm	0.000108	0.00566	CbGpPWpGaD
Abiraterone—ALB—Platelet degranulation—KNG1—peripheral nervous system neoplasm	9.9e-05	0.00517	CbGpPWpGaD
Abiraterone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	9.54e-05	0.00499	CbGpPWpGaD
Abiraterone—ALB—Response to elevated platelet cytosolic Ca2+—KNG1—peripheral nervous system neoplasm	9.43e-05	0.00493	CbGpPWpGaD
Abiraterone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	9.09e-05	0.00475	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.62e-05	0.0045	CbGpPWpGaD
Abiraterone—ALB—Platelet degranulation—HGF—peripheral nervous system neoplasm	8.24e-05	0.00431	CbGpPWpGaD
Abiraterone—ALB—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	7.85e-05	0.0041	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.7e-05	0.00402	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	7.41e-05	0.00387	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	7.17e-05	0.00374	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—ENO2—peripheral nervous system neoplasm	7.12e-05	0.00372	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	6.38e-05	0.00333	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	6.34e-05	0.00331	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—GNS—peripheral nervous system neoplasm	6.23e-05	0.00326	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—BCHE—peripheral nervous system neoplasm	6.01e-05	0.00314	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—NME1—peripheral nervous system neoplasm	5.98e-05	0.00312	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—COX2—peripheral nervous system neoplasm	5.75e-05	0.00301	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.74e-05	0.003	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—TH—peripheral nervous system neoplasm	5.65e-05	0.00295	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.2e-05	0.00272	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—GNAS—peripheral nervous system neoplasm	4.62e-05	0.00241	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—ABCB1—peripheral nervous system neoplasm	4.53e-05	0.00237	CbGpPWpGaD
Abiraterone—ABCC1—Disease—GNS—peripheral nervous system neoplasm	4.49e-05	0.00235	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	4.39e-05	0.00229	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.32e-05	0.00226	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.2e-05	0.0022	CbGpPWpGaD
Abiraterone—ALB—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	4.19e-05	0.00219	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.18e-05	0.00218	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	4.02e-05	0.0021	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.92e-05	0.00205	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—ENO2—peripheral nervous system neoplasm	3.78e-05	0.00197	CbGpPWpGaD
Abiraterone—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	3.77e-05	0.00197	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GNS—peripheral nervous system neoplasm	3.76e-05	0.00196	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	3.66e-05	0.00191	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—NME1—peripheral nervous system neoplasm	3.61e-05	0.00188	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—COX2—peripheral nervous system neoplasm	3.47e-05	0.00181	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.45e-05	0.0018	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—TP53—peripheral nervous system neoplasm	3.23e-05	0.00169	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—BCHE—peripheral nervous system neoplasm	3.19e-05	0.00167	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.15e-05	0.00165	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PPP3R1—peripheral nervous system neoplasm	3.14e-05	0.00164	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.1e-05	0.00162	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.04e-05	0.00159	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—TH—peripheral nervous system neoplasm	3e-05	0.00157	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.84e-05	0.00148	CbGpPWpGaD
Abiraterone—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.82e-05	0.00148	CbGpPWpGaD
Abiraterone—ABCC1—Disease—ENO2—peripheral nervous system neoplasm	2.72e-05	0.00142	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—GNAS—peripheral nervous system neoplasm	2.45e-05	0.00128	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	2.44e-05	0.00128	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.4e-05	0.00126	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.36e-05	0.00123	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.35e-05	0.00123	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.33e-05	0.00122	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—ENO2—peripheral nervous system neoplasm	2.28e-05	0.00119	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	2.26e-05	0.00118	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.26e-05	0.00118	CbGpPWpGaD
Abiraterone—ABCC1—Disease—SLC2A1—peripheral nervous system neoplasm	2.19e-05	0.00115	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.13e-05	0.00111	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	2.05e-05	0.00107	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GNS—peripheral nervous system neoplasm	2.04e-05	0.00107	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	1.98e-05	0.00103	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	1.97e-05	0.00103	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NME1—peripheral nervous system neoplasm	1.96e-05	0.00102	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—BCHE—peripheral nervous system neoplasm	1.93e-05	0.00101	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	1.9e-05	0.00099	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	1.88e-05	0.000985	CbGpPWpGaD
Abiraterone—ALB—Metabolism—COX2—peripheral nervous system neoplasm	1.88e-05	0.000984	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.84e-05	0.000959	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—TH—peripheral nervous system neoplasm	1.81e-05	0.000946	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.71e-05	0.000895	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	1.69e-05	0.000881	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.68e-05	0.000878	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	1.62e-05	0.000844	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	1.56e-05	0.000813	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.52e-05	0.000796	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GNAS—peripheral nervous system neoplasm	1.48e-05	0.000772	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.45e-05	0.000757	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	1.38e-05	0.000718	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—AKT1—peripheral nervous system neoplasm	1.25e-05	0.000651	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	1.24e-05	0.00065	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	1.24e-05	0.000646	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PTPN11—peripheral nervous system neoplasm	1.23e-05	0.000641	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	1.1e-05	0.000576	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	1.06e-05	0.000552	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	1.05e-05	0.000549	CbGpPWpGaD
Abiraterone—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	1.05e-05	0.000546	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	1.04e-05	0.000541	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	1.02e-05	0.000534	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	1.02e-05	0.000531	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	1e-05	0.000524	CbGpPWpGaD
Abiraterone—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.97e-06	0.000521	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	9.88e-06	0.000516	CbGpPWpGaD
Abiraterone—ALB—Metabolism—TH—peripheral nervous system neoplasm	9.83e-06	0.000513	CbGpPWpGaD
Abiraterone—ABCC1—Disease—ERBB2—peripheral nervous system neoplasm	9.69e-06	0.000506	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	8.63e-06	0.000451	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	8.27e-06	0.000432	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.23e-06	0.00043	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	8.11e-06	0.000424	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	8.07e-06	0.000422	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	8.02e-06	0.000419	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	7.92e-06	0.000414	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	7.87e-06	0.000411	CbGpPWpGaD
Abiraterone—ABCC1—Disease—NRAS—peripheral nervous system neoplasm	7.37e-06	0.000385	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MYC—peripheral nervous system neoplasm	6.87e-06	0.000359	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	6.68e-06	0.000349	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	6.62e-06	0.000346	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—AKT1—peripheral nervous system neoplasm	6.61e-06	0.000345	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	6.5e-06	0.00034	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	6.32e-06	0.00033	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	6.05e-06	0.000316	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	5.64e-06	0.000295	CbGpPWpGaD
Abiraterone—ABCC1—Disease—HRAS—peripheral nervous system neoplasm	5.39e-06	0.000282	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.38e-06	0.000281	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	5.34e-06	0.000279	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	5.31e-06	0.000277	CbGpPWpGaD
Abiraterone—ABCC1—Disease—AKT1—peripheral nervous system neoplasm	4.76e-06	0.000249	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	4.33e-06	0.000226	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	4.25e-06	0.000222	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—AKT1—peripheral nervous system neoplasm	3.99e-06	0.000208	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	2.18e-06	0.000114	CbGpPWpGaD
Abiraterone—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	2.17e-06	0.000113	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	1.79e-06	9.34e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.17e-06	6.11e-05	CbGpPWpGaD
